Evolent Health Company Top Insiders
| EVH Stock | USD 29.26 0.87 2.89% |
Evolent Health's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Evolent Health suggests that almost all insiders are panicking. Evolent Health employs about 4.7 K people. The company is managed by 39 executives with a total tenure of roughly 229 years, averaging almost 5.0 years of service per executive, having 120.51 employees per reported executive.
| Seth Blackley CEO Chief Executive Officer, Co-Founder, Director |
| Frank Williams Chairman Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee |
Evolent Health's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
| 2023-12-05 | Seth Blackley | Disposed 141000 @ 26.54 | View | ||
| 2023-11-15 | Daniel Joseph Mccarthy | Disposed 11000 @ 30 | View | ||
| 2023-06-28 | Seth Blackley | Disposed 33011 @ 30.78 | View | ||
| 2023-06-16 | Seth Blackley | Disposed 2098 @ 30.16 | View | ||
| 2023-06-14 | Cheryl Scott | Disposed 2365 @ 30.01 | View | ||
| 2023-06-12 | Diane Holder | Disposed 12000 @ 31.26 | View | ||
| 2023-06-01 | Frank J Williams | Disposed 110000 @ 29.52 | View | ||
| 2023-05-01 | Frank J Williams | Disposed 110000 @ 36.29 | View |
Monitoring Evolent Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Evolent |
Evolent Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Evolent Health's future performance. Based on our forecasts, it is anticipated that Evolent will maintain a workforce of under 4700 employees by May 2024.Evolent Health's latest congressional trading
Congressional trading in companies like Evolent Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Evolent Health by those in governmental positions are based on the same information available to the general public.
| 2020-05-11 | Representative Greg Gianforte | Acquired $50K to $100K | Verify |
Evolent Health Management Team Effectiveness
The current Return On Tangible Assets is estimated to decrease to -0.15. The current Return On Capital Employed is estimated to decrease to -0.04. As of now, Evolent Health's Fixed Asset Turnover is increasing as compared to previous years. Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.The current Common Stock Shares Outstanding is estimated to decrease to about 76.8 M. The current Net Loss is estimated to decrease to about (18.1 M)
Evolent Health Workforce Comparison
Evolent Health is one of the top stocks in number of employees category among related companies. The total workforce of Health Care industry is currently estimated at about 7,252. Evolent Health totals roughly 4,700 in number of employees claiming about 65% of equities under Health Care industry.
The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.01 %, which entails that for every 100 dollars of revenue, it generated $0.01 of operating income. Evolent Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evolent Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evolent Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Evolent Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2023-12-01 | 0.25 | 2 | 8 | 283,000 | 433,490 |
| 2023-09-01 | 0.1429 | 1 | 7 | 4,386 | 50,482 |
| 2023-06-01 | 0.6522 | 15 | 23 | 481,432 | 903,009 |
| 2023-03-01 | 0.5152 | 17 | 33 | 1,546,302 | 1,959,501 |
| 2022-12-01 | 0.3 | 3 | 10 | 295,000 | 590,000 |
| 2022-09-01 | 0.125 | 1 | 8 | 17,247 | 159,955 |
| 2022-06-01 | 9.0 | 9 | 1 | 50,076 | 3,860 |
| 2022-03-01 | 0.4167 | 10 | 24 | 453,809 | 966,247 |
| 2021-12-01 | 0.3846 | 5 | 13 | 183,405 | 390,000 |
| 2021-09-01 | 0.4762 | 20 | 42 | 175,318 | 402,716 |
| 2021-06-01 | 1.1818 | 13 | 11 | 119,417 | 125,052 |
| 2021-03-01 | 7.0 | 7 | 1 | 164,590 | 0.00 |
| 2020-09-01 | 0.5 | 1 | 2 | 10,000 | 20,000 |
| 2020-06-01 | 1.3333 | 8 | 6 | 268,114 | 99,530 |
| 2020-03-01 | 6.0 | 6 | 1 | 530,219 | 0.00 |
| 2019-09-01 | 0.4 | 2 | 5 | 22,200 | 80,222 |
| 2018-09-01 | 0.3103 | 9 | 29 | 245,440 | 735,559 |
| 2018-06-01 | 0.5625 | 9 | 16 | 58,672 | 3,189,979 |
| 2018-03-01 | 6.0 | 12 | 2 | 2,486,174 | 4,812,898 |
| 2017-09-01 | 0.3077 | 4 | 13 | 27,700 | 114,507 |
| 2017-06-01 | 0.403 | 27 | 67 | 8,034,433 | 20,455,695 |
| 2017-03-01 | 0.6071 | 17 | 28 | 4,713,444 | 11,742,278 |
| 2016-09-01 | 0.5238 | 11 | 21 | 2,037,829 | 10,427,023 |
| 2016-06-01 | 1.0 | 1 | 1 | 8,183 | 0.00 |
| 2015-12-01 | 2.0 | 2 | 1 | 12,954 | 0.00 |
| 2015-06-01 | 0.0227 | 1 | 44 | 2,000 | 13,768,760 |
Evolent Health Notable Stakeholders
An Evolent Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Evolent Health often face trade-offs trying to please all of them. Evolent Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Evolent Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dan McCarthy | CEO President | Profile | |
| Seth Blackley | Chief Executive Officer, Co-Founder, Director | Profile | |
| Frank Williams | Co-Founder, CEO, Director and Chairman of Nominating and Governance Committee | Profile | |
| Nicholas McGrane | Executive Vice President of Corporate Performance | Profile | |
| John Johnson | Chief Financial Officer | Profile | |
| Thomas Peterson | Chief Operating Officer | Profile | |
| Steve Tutewohl | Chief Operating Officer | Profile | |
| Charles Pomeroy | Chief Technology Officer | Profile | |
| Matthew Hobart | Independent Director | Profile | |
| Bridget Duffy | Independent Director | Profile | |
| Norman Payson | Director | Profile | |
| Bruce Felt | Independent Director | Profile | |
| Kenneth Samet | Independent Director | Profile | |
| Michael Kirshbaum | Director | Profile | |
| Cheryl Scott | Lead Independent Director | Profile | |
| David Farner | Director | Profile | |
| Robert Musslewhite | Director | Profile | |
| Diane Holder | Director | Profile | |
| Michael DAmato | Independent Director | Profile | |
| Kim Keck | Independent Director | Profile | |
| Jonathan JD | General Officer | Profile | |
| Lydia Stone | Chief Accounting Officer, Corporate Controller | Profile | |
| Robert Cruz | Chief Officer | Profile | |
| Gary Piefer | Chief Medical Officer | Profile | |
| John MD | Chief Officer | Profile | |
| Tunde Sotunde | Independent Director | Profile | |
| Steven Wigginton | Chief Devel. Officer | Profile | |
| MAAA FSA | Chief Officer | Profile | |
| Emily Rafferty | Chief Officer | Profile | |
| M Duffy | Independent Director | Profile | |
| Craig Barbarosh | Independent Director | Profile | |
| Dave Thornton | Chief Talent Officer | Profile | |
| Jonathan Weinberg | General Counsel | Profile | |
| Aammaad Shams | Interim Principal Accounting Officer and Corporate Controller | Profile | |
| Jessica Somers | Sr Devel | Profile | |
| Seth Frank | Vice Relations | Profile | |
| Peter Grua | Independent Director | Profile | |
| Kali Beyah | Chief Officer | Profile | |
| Jessica White | Chief Officer | Profile |
About Evolent Health Management Performance
The success or failure of an entity such as Evolent Health often depends on how effective the management is. Evolent Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Evolent management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Evolent management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.04) | (0.04) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.11) | (0.10) |
The data published in Evolent Health's official financial statements usually reflect Evolent Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Evolent Health. For example, before you start analyzing numbers published by Evolent accountants, it's critical to develop an understanding of what Evolent Health's liquidity, profitability, and earnings quality are in the context of the Health Care Technology space in which it operates.
Please note, the presentation of Evolent Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evolent Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Evolent Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Evolent Health. Please utilize our Beneish M Score to check the likelihood of Evolent Health's management manipulating its earnings.
Evolent Health Workforce Analysis
Traditionally, organizations such as Evolent Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Evolent Health within its industry.Evolent Health Manpower Efficiency
Return on Evolent Health Manpower
| Revenue Per Employee | 417.9K | |
| Revenue Per Executive | 50.4M | |
| Net Loss Per Employee | 24.1K | |
| Net Loss Per Executive | 2.9M | |
| Working Capital Per Employee | 2K | |
| Working Capital Per Executive | 241.8K |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Evolent Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.28) | Revenue Per Share 17.653 | Quarterly Revenue Growth 0.454 | Return On Assets 0.0086 | Return On Equity (0.11) |
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.